| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd9c6ddd7d27c986a7be6a2c7ca303f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1129603b7f55c11a7e6f09b87fc993c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d84917e755129b153536b6430c51864 |
| publicationDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018354959-A1 |
| titleOfInvention |
Therapeutic compounds, compositions and methods of use thereof |
| abstract |
Compounds of Formula (I): n n n n n n n n n n salts thereof and methods of use as Janus kinase inhibitors are described herein. |
| priorityDate |
2016-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |